Ketki Kinkar, Brandon K. K. Fields, Mary W. Yamashita, Bino A. Varghese
{"title":"Empowering breast cancer diagnosis and radiology practice: advances in artificial intelligence for contrast-enhanced mammography","authors":"Ketki Kinkar, Brandon K. K. Fields, Mary W. Yamashita, Bino A. Varghese","doi":"10.3389/fradi.2023.1326831","DOIUrl":null,"url":null,"abstract":"Artificial intelligence (AI) applications in breast imaging span a wide range of tasks including decision support, risk assessment, patient management, quality assessment, treatment response assessment and image enhancement. However, their integration into the clinical workflow has been slow due to the lack of a consensus on data quality, benchmarked robust implementation, and consensus-based guidelines to ensure standardization and generalization. Contrast-enhanced mammography (CEM) has improved sensitivity and specificity compared to current standards of breast cancer diagnostic imaging i.e., mammography (MG) and/or conventional ultrasound (US), with comparable accuracy to MRI (current diagnostic imaging benchmark), but at a much lower cost and higher throughput. This makes CEM an excellent tool for widespread breast lesion characterization for all women, including underserved and minority women. Underlining the critical need for early detection and accurate diagnosis of breast cancer, this review examines the limitations of conventional approaches and reveals how AI can help overcome them. The Methodical approaches, such as image processing, feature extraction, quantitative analysis, lesion classification, lesion segmentation, integration with clinical data, early detection, and screening support have been carefully analysed in recent studies addressing breast cancer detection and diagnosis. Recent guidelines described by Checklist for Artificial Intelligence in Medical Imaging (CLAIM) to establish a robust framework for rigorous evaluation and surveying has inspired the current review criteria.","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"11 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fradi.2023.1326831","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Artificial intelligence (AI) applications in breast imaging span a wide range of tasks including decision support, risk assessment, patient management, quality assessment, treatment response assessment and image enhancement. However, their integration into the clinical workflow has been slow due to the lack of a consensus on data quality, benchmarked robust implementation, and consensus-based guidelines to ensure standardization and generalization. Contrast-enhanced mammography (CEM) has improved sensitivity and specificity compared to current standards of breast cancer diagnostic imaging i.e., mammography (MG) and/or conventional ultrasound (US), with comparable accuracy to MRI (current diagnostic imaging benchmark), but at a much lower cost and higher throughput. This makes CEM an excellent tool for widespread breast lesion characterization for all women, including underserved and minority women. Underlining the critical need for early detection and accurate diagnosis of breast cancer, this review examines the limitations of conventional approaches and reveals how AI can help overcome them. The Methodical approaches, such as image processing, feature extraction, quantitative analysis, lesion classification, lesion segmentation, integration with clinical data, early detection, and screening support have been carefully analysed in recent studies addressing breast cancer detection and diagnosis. Recent guidelines described by Checklist for Artificial Intelligence in Medical Imaging (CLAIM) to establish a robust framework for rigorous evaluation and surveying has inspired the current review criteria.
人工智能(AI)在乳腺成像中的应用范围广泛,包括决策支持、风险评估、患者管理、质量评估、治疗反应评估和图像增强。然而,由于缺乏对数据质量的共识、以基准为基础的稳健实施以及基于共识的指南来确保标准化和通用化,它们与临床工作流程的整合一直进展缓慢。与目前的乳腺癌诊断成像标准(即乳腺 X 线照相术(MG)和/或传统超声波(US))相比,对比增强乳腺 X 线照相术(CEM)具有更高的灵敏度和特异性,其准确性与核磁共振成像(目前的诊断成像基准)相当,但成本更低,吞吐量更大。这使得 CEM 成为一种优秀的工具,可广泛用于所有妇女(包括服务不足的妇女和少数民族妇女)的乳腺病变特征描述。本综述强调了早期检测和准确诊断乳腺癌的迫切需要,探讨了传统方法的局限性,并揭示了人工智能如何帮助克服这些局限性。在最近针对乳腺癌检测和诊断的研究中,对图像处理、特征提取、定量分析、病灶分类、病灶分割、与临床数据整合、早期检测和筛查支持等方法进行了仔细分析。医学影像人工智能核对表(CLAIM)所描述的最新指导方针为严格的评估和调查建立了一个稳健的框架,这也启发了当前的审查标准。